PABA: benefits, dosage, contraindications

Updated on

Para-aminobenzoic acid (PABA) is a natural non-protein amino acid. It is found in foods such as liver, eggs, kidneys, wheat germ, bran, milk, and yogurt. It was once thought to be a B vitamin, but it is now known that it is neither a vitamin nor an essential nutrient for humans. Interestingly, pathogenic bacteria require PABA to synthesize folic acid. Sulfonamide antibiotics exert their antibacterial effect by inhibiting the synthesis of folic acid from PABA. PABA first appeared as a sunscreen agent after World War II due to its ability to absorb ultraviolet B rays. Orally, PABA is used for vitiligo, inflammatory myopathies, Peyronie's disease (a disease causing erectile dysfunction), anemia, systemic lupus erythematosus, and headaches. It is also used for gray hair, hair loss, and skin aging.

Other name(s) 

Vitamin B10

Scientific name(s)

Para-aminobenzoic acid

Family or group: 

Amino acids


Indications

Rating methodology

EFSA approval.

Several clinical trials (> 2) randomized controlled with double blind, including a significant number of patients (>100) with consistently positive outcomes for the indication.
Several clinical trials (> 2) randomized controlled with double blind, and including a significant number of patients (>100) with positive outcomes for the indication.
One or more randomized studies or multiple cohorts or epidemiological studies with positive outcomes for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or contradictory.
Lack of clinical studies to date that can demonstrate the indication.


UV exposure
✪✪✪✪✪

PABA was once widely used as an active ingredient in sunscreens for its effectiveness in blocking UVB rays, thereby helping prevent skin damage caused by sun exposure. PABA is an FDA-approved sunscreen.

Posologie

posologieTopical


Peyronie's Disease
✪✪✪✪✪

PABA is administered exogenously in fibrotic diseases such as dermatomyositis, pemphigus, Peyronie's disease, and scleroderma. Fibrosis could be caused by a long-term imbalance of serotonin and monoamine oxidase (MAO) activity in tissues. MAO requires significant tissue oxygenation to function properly. PABA may enhance MAO activity by increasing tissue oxygenation.a PABA is FDA-approved for the treatment of Peyronie's disease.

Posologie

posologieOral


Hair beauty
✪✪✪✪

PABA is reputed for darkening gray hair, although specific studies are lacking to fully validate these effects.

Posologie

posologieOral


Properties


Dermatological effect

full-leaffull-leaffull-leafempty-leaf

Para-aminobenzoic acid was first discovered as a remedy for depigmentation in laboratory mice fur. PABA, when used orally, can darken gray hair, although its precise mechanism on melanin metabolism remains unknown. When applied topically, PABA serves as a sunscreen filter, blocking ultraviolet UVB rays and providing protection against UVA at high concentrations. This photoprotective action preserves epidermal cells.

Usages associés

UV exposure, Hair beauty


Safety dosage

Adult: 12 g

The oral dosage of PABA for inflammatory myopathies, pemphigus, and scleroderma is 12 g per day in 4 to 6 doses. For Peyronie's disease, a dose of 12 g per day in four divided doses with meals has been used for 8 to 24 months. PABA sunscreens are available in concentrations from 1% to 15%.